Clinical trial
Evaluating the Effectiveness and Feasibility of Reactive Focal Mass Drug Administration vs. Reactive Case Detection as a Community Level Intervention in Response to a Passively Identified Index Malaria Case in Swaziland
NCT02315690 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating the Effectiveness and Feasibility of Reactive Focal Mass Drug Administration vs. Reactive Case Detection as a Community Level Intervention in Response to a Passively Identified Index Malaria Case in Swaziland
- Lead sponsor
- University of California, San Francisco
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 30, 2015
- Completion date
- July 31, 2017
- Enrollment
- 4,000 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.